Thursday, July 12, 2007

MedApps D-PAL™ Remote Patient Monitoring System for Diabetes

Filed under: Telemedicine

A wireless system to transmit daily glucose readings from a patient's glucometer via cellphone into a central server, developed by a Scottsdale, Arizona startup MedApps, Inc., has been approved by the FDA for for over-the-counter use. We have briefly mentioned this system about a year ago.

Here's how this telemedicine system works:

D-PAL currently combines with the Polymap Polytel(R) device which connects to the LifeScan(R) OneTouch(R) Ultra(R) and sends the data via Bluetooth(R) (wireless) to the patient's cell phone (acting as a "Hub") and transmits the information to the central server in near real-time. D-PAL is the first of a series of medical devices that integrates with the MedApps System and enables patients with chronic diseases to lead more active lifestyles. Additional integrated devices will include scales, blood pressure monitors, spirometers, pulse oximeters, ECG, and a variety of implantable devices such as pacemakers.

Pre-established thresholds are set for each patient by their healthcare provider(s). When a reading occurs outside of these thresholds, an alert may occur and the patient may be contacted using a pre-determined mode. One
such mode is an interactive voice response system which can qualify additional behavioral information by asking questions such as, "Have you exercised today?" or "Have you taken your medication?" The responses to these questions, combined with previously collected biometric data, can give healthcare professionals greater insight into a patient's health.

The MedApps Telemedicine 2.0 Wireless System, allows medical providers to monitor trends in their patients' health with accurate, timely readings. Healthcare professionals and patient management companies have greater accessibility to better information and no longer have to rely on patients to submit their own readings, while the patient, in turn, is encouraged to live a more active lifestyle. As patients lose mobility, they must curtail daily activities, in essence giving "control" of their lives to their disease. This loss of control signals a downward spiral toward immobilization, inpatient encounters, and costly ER visits. MedApps helps stabilize patient treatments, allows timely interventions, and gives patients more control over their diseases.


Press release (.pdf)...

Product page: MedApps D-PAL™ Remote Patient Monitoring System...

Flashbacks: Let Your Cellphone Monitor, Transfer Your Vitals & More ; Wireless Monitoring of Diabetics

(hat tip: The Medical Quack)

email this article to a friend      print this!           comments and peer reviews (2)






replies: 2 comments
Open comments are not moderated, although abusive and vulgar remarks may be deleted. Opinions expressed do not necessarily reflect the views of Medgadget.com. Please consult our disclaimer.

There is an entire category of wireless diabetes devices launching this year.

What's more important however is the clinical trial data from actual patient use of these cool devices if the manufacturers ever hope for adoption by the medical community.

Much of the 1.1 point drop in A1c experienced by 84% of the patients in the healthcordia trial can be attributed to the simplicity of the GlucoMON®wireless glucose meter device, relevance of the system interactions and the comprehensive nature of the program delivery itself.

We'll have to see how the MedApps kit fares in patient usability studies before we can extend prior research outcomes to other programs that use other more complex devices.

Our understanding is that the MedApps Bluetooth solution involves a regular glucose meter, a third party counter-top device which the patient uses to connect a cable to the meter, the counter-top device in turn communicates via Bluetooth (short-range wireless) to the patient's Bluetooth enabled cell phone, the cell phone in turn receives the data from the counter-top device and in turn transmits the data via the patient's cell phone add-on data plan to a remote system with Internet connectivity where the data is stored, viewed, etc...

Fortunately, healthcordia, llc announced impressive clinical trial results at this year's ADA Scientific Sessions with hard data from actual type 2 adults using Diabetech's GlucoMON� wireless glucose meter, a sophisticated GlucoDYNAMIX� rules engine, and patient-centric social networks.

The key to outcomes is simplicity, relevance and ultimately its ability to effect behavioral changes. MedApps and the other vendors will have to go through similar usability studies and healthcordia is best positioned to evaluate comparative analysis given its incumbent position managing patients with this sort of wireless diabetes technology.

Ideally, the device community will pay attention to outcomes and patients will ultimately win by having a large portfolio of field-tested and easy to use devices that are capable of supporting patient programs.


Posted by: Kevin
on July 15, 2007 08:37 PM GMT

Does anyone have information on reimbursement / HMO coverage for ICU patient monitoring systems ?


Posted by: jason
on December 12, 2007 10:13 AM GMT

add a comment
html tags: <b>, <i>, and <a>
examples: <b>Bold</b> <i>Italic</i>









Remember personal info?
(anonymous comments allowed)



click to make your selection boldclick to make your selection italicclick to add a link


Verification (needed to reduce spam):




Click the "Post" button only once!